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Abstract
Background: Milk intake has been associated with lower blood pressure (BP) in observa-
tional studies, and randomized controlled trials suggested that milk-derived tripeptides
have BP-lowering effects. Milk intake has also been associated with body mass index
(BMI). Nevertheless, it is unclear whether increasing milk consumption would reduce BP
in the general population.
Methods: We investigated the association of milk intake with obesity and BP using
genetically-defined lactase persistence (LP) based on the rs4988235 polymorphism in a
Mendelian randomization design in the 1982 Pelotas (Southern Brazil) Birth Cohort.
These results were combined with published reports identified through a systematic
review using meta-analysis.
Results: In the 1982 Pelotas Birth Cohort, milk intake was 42 [95% confidence interval
(CI): 18; 67) ml/day higher in LP individuals. In conventional observational analysis, each
1-dl/day increase in milk intake was associated with 0.26 (95% CI: 0.33; 0.19) kg/m2
in BMI and 0.31 (95% CI: 0.46; 0.16) and -0.35 (95% CI: 0.46; 0.23) mmHg in sys-
tolic and diastolic BP, respectively. These results were not corroborated when analysing
LP status, but confidence intervals were large. In random effects meta-analysis, LP indi-
viduals presented higher BMI [0.17 (95% CI: 0.07; 0.27) kg/m2] and higher odds of over-
weight-obesity [1.09 (95% CI: 1.02; 1.17)]. There were no reliable associations for BP.
Conclusions: Our study supports that LP is positively associated with obesity, suggesting
that the negative association of milk intake with obesity is likely due to limitations of
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conventional observational studies. Our findings also do not support that increased milk
intake leads to lower BP.
Key words: Lactase persistence, milk, body mass index, obesity, blood pressure, Mendelian randomization
Introduction
Single nucleotide polymorphisms (SNPs) in the enhancer
region of the LCT gene [OMIM: 603202] are functionally
associated with adult-type hypolactasia;1 rs4988235 (a C
to T SNP located 13910 base pairs downstream of the
LCT gene) is one such SNP, whose association with lactase
persistence (LP)—maintenance of lactase expression after
weaning [MIM: 223100]—was first identified in Finland.2
The presence of the T allele (i.e. CT and TT genotypes)
correlated perfectly with LP, which is considered an auto-
somal dominant trait3 even though the effects at the gene
expression level are additive.4,5 This association was corro-
borated by several functional studies4,6–9 which revealed
the causal effect of rs4988235 on LP. Further genetic vari-
ability in this region has been described in non-Europeans,
including admixed populations such as Brazil.10 The
gastrointestinal symptoms in response to lactose that occur
(at varying levels) in individuals with adult-type hypolacta-
sia motivated investigation of the positive association be-
tween LP and intake of milk and other dairy
products.2,11,12 This association was observed in several
populations13–18 but not universally, possibly for cultural
reasons involved with acceptance and generality of milk
drinking.19,20
Cardiovascular diseases are the leading cause of death
worldwide. Ischaemic heart disease and stroke were esti-
mated to have caused around 25% of deaths in the world
in 2010.21 Nevertheless, much of this burden is considered
preventable. For example, the risk of developing coronary
heart disease was 83% lower in women presenting a
healthy lifestyle in a prospective study (14 years of follow-
up) of approximately 80 000 healthy (at baseline) partici-
pants in the Nurses’ Health Study.22 Among many aspects
of diet, intake of milk and other dairy products has been
suggested to protect against cardiovascular diseases
through a blood pressure-lowering effect. Associations of
milk with lower risk of hypertension have been reported in
several observational studies.23,24 In addition, randomized
controlled trials (RCTs) indicate that specific milk compo-
nents may lower blood pressure.25,26
Some studies also detected associations between dairy
consumption and body mass index (BMI), but the litera-
ture is controversial. Observational studies in children re-
ported positive associations between milk consumption
and BMI, especially in children of 4 years of age or
younger.27,28 However, a meta-analysis of 22 studies failed
to detect such association, although a negative association
between dairy intake and adiposity in adolescents was de-
tected.29 In adults, a prospective study in almost 100 000
Danish individuals identified a positive association be-
tween intake of any type of milk and risk of overweight-
obesity; however, there was no dose-response relationship,
and the association was observed for fat-free, but not for
high-fat, milk.30 Moreover, replacing water with milk was
associated with increased total energy intake in a system-
atic review of intervention studies, although these findings
were not considered conclusive.31 Findings from three co-
hort studies with a total sample size of more than 120 000
adults failed to detect an association between whole- and
low-fat milk intake and prospective weight gain, in
Key Messages
• Genetically defined lactase persistence (LP) was associated with more milk intake in the 1982 Pelotas Birth Cohort,
and this association was more pronounced among individuals of more European ancestry.
• Milk intake was negatively associated with obesity and blood pressure in conventional observational analysis in the
1982 Pelotas Birth Cohort.
• LP was positively associated with BMI and overweight-obesity in our meta-analysis which was based on a systematic
literature review.
• There were no reliable meta-analytical associations between LP and blood pressure, thus not supporting the notion
that milk intake is causally associated with lower blood pressure.
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multivariable analysis. However, individuals who replaced
sugar-sweetened beverages and fruit juices with milk pre-
sented lower prospective weight gain than their counter-
parts,32 suggesting the association between milk
consumption and BMI might be influenced by overall diet-
ary patterns. Therefore, the direction of the association (if
any) of milk intake with obesity is unclear.
The use of genetic variants as proxies of modifiable ex-
posures can improve causal inference in observational
studies through applying the principle of Mendelian ran-
domization.33 Appropriately performed, Mendelian ran-
domization studies are not prone to confounding or
reverse causation and, given that its assumptions (i.e. no
confounding by population stratification or by horizontal
pleiotropy) are not violated, provide a strategy to obtain
causal effect estimates in observational studies.34,35
Associations involving LP status and cardiovascular risk
factors have already been reported in the literature. A
meta-analysis involving 31 720 Europeans reported that T-
allele carriers (i.e. LP individuals) had higher BMI than CC
individuals (i.e. non-persistents).36 Given that genetically-
defined LP has been associated with higher milk intake in
these populations,13–18 the association between LP and
BMI may be due to differences in milk consumption.
However, the aforementioned large Danish study did not
detect strong associations with obesity and blood
pressure.30,37
In the present study, we evaluated whether genetically-
defined LP is associated with milk intake, obesity and
blood pressure among subjects who have been followed up
since birth in a southern Brazilian city. We also combined
these results with published data identified through a sys-
tematic review of the literature.
Methods
1982 Pelotas Birth Cohort
Study participants and data collection
In 1982, the maternity hospitals in Pelotas, a southern
Brazilian city (current population 330 000), were visited
daily by trained interviewers, who were health profes-
sionals with an academic degree. The 5914 liveborns
whose families lived in the urban area were examined and
their mothers interviewed. We were able to get information
of more than 99% of the live births. These subjects have
been followed-up nine times (five follow-ups targeting sub-
samples and four targeting the whole cohort). From
October 2004 to August 2005, we visited all households
located in the urban area of the city. For those not located
in this way we used the last known address. Subjects (aged
22–23 years) were interviewed and examined at home and
invited to visit the research laboratory to donate a blood
sample, collected by venous puncture. DNA and sera were
extracted and frozen at 70C. DNA samples were geno-
typed using the Illumina HumanOmni2.5-8v1 array.38,39
From June 2012 to February 2013, all cohort participants
(aged 30–31 years) were invited to visit the research clinic
to be interviewed and examined.39 A total of 3701 subjects
were interviewed in the 2012–13 follow-up visit. Taking
into account the 325 individuals who are known to have
died, this represents a follow-up rate of 68.1%. Among
these, 2843 (comprising the group included in the present
study) had data for the rs4988235 SNP and at least one
studied outcome (i.e. BMI, systolic or diastolic blood pres-
sure) (Supplementary Figure 1, available as Supplementary
data at IJE online).
Exposure variables were rs4988235 SNP and dairy in-
take. We selected the rs4988235 SNP as a potential genetic
proxy of milk consumption due to its role in LP.2,7–9 Daily
dairy consumption (milk and yogurt in ml/day, and cheese
and cottage cheese in g/day) was measured using a food
frequency questionnaire with a 1-year recall in the 2012–
13 follow-up (when individuals were 30–31 years of age).
Outcome variables were: BMI, overweight-obesity, sys-
tolic blood pressure, diastolic blood pressure and raised
blood pressure. For BMI (kg/m2), weight and height were
measured using portable weighing devices and stadiome-
ters of 100 g and 1 cm of precision, respectively.
Overweight-obesity was defined as BMI 25 kg/m2.
Systolic and diastolic blood pressures were measured in
mmHg using an Omron HEM-705CPINT digital sphyg-
momanometer; two measurements were taken and their
mean was used for the analyses. Raised blood pressure was
defined as systolic BP 130 mmHg or diastolic
BP 85 mmHg. These variables were measured in the
2012–13 follow-up.
Covariate variables were: sex, maternal schooling at
birth (in complete years of education of the mothers), fam-
ily income at birth, birthweight and gestational age based
on the maternal recall of the date of the last menstrual
period (measured at birth); self-reported skin colour, gen-
omic ancestry (European, African and Native American)
and leisure-time physical activity (using the International
Physical Activity Questionnaire) (measured at the 2004–04
visit, when individuals were 22–23 years of age); and
household asset index, achieved schooling in complete
years, smoking, alcohol intake, low-density lipoprotein
(LDL) and height (measured in the 2012–13 visit, when in-
dividuals were 30–31 years of age). Household asset index
was obtained by applying principal component analysis to
a list of 12 assets and the schooling of the household
head.40 Genomic ancestry was estimated using
ADMIXTURE41 based on 370 000 SNPs mutually
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available for the 1982 Pelotas Birth Cohort and reference
panels from the HapMap and Human Genome Diversity
projects, as described elsewhere.42
Statistical analysis
Hardy-Weinberg equilibrium (HWE) and distribution of
rs4988235 genotypes according to observed skin colour
were evaluated using Fisher’s exact and v2 tests, respect-
ively. Unadjusted associations of milk intake status (none
vs any) with sociodemographic, perinatal, lifestyle and bio-
logical variables were evaluated using the v2 test (for cat-
egorical variables) or the t test (for continuous variables).
The remaining analyses were performed by linear or logis-
tic regression. To account for population stratification, es-
timates were adjusted for quantitative indicators of
genomic ancestry (European, African and Native
American) when indicated. Two genetic effect models were
used: codominant (i.e. each genotype is coded as a distinct
category) and dominant (i.e. CC¼ 0; CT or TT¼ 1). The
codominant effect is the generic model, whereas the dom-
inant effect is the most strongly supported by the literature
regarding the consequences of lactase non-persistence at
the distal phenotypic level (e.g. on milk intake).3
Systematic review and meta-analysis
A systematic review of the literature regarding the associ-
ation of LP with obesity and blood pressure was performed
through Ovid [https://ovidsp.tx.ovid.com/] which allows
simultaneously searching the following databases:
MEDLINE, Embase, Allied and Complementary Medicine
Database, CAB ABSTRACTS, PsycINFOV
R
and The
Philosopher’s Index. The following combination of search
terms was used: ‘LP’ AND (‘BMI’ OR ‘Blood pressure’ OR
‘Other’). A detailed description of each search term, as
well as the number of records retrieved by each in isola-
tion, is provided in Supplementary Tables 1 and 2, respect-
ively (available as Supplementary data at IJE online). The
resulting records were independently evaluated by two re-
viewers, and disagreements were resolved by consensus.
Studies that analysed the association of the rs4988235
variant (exposure) with the following outcomes: BMI (con-
tinuous), overweight-obesity (binary), systolic and diastolic
blood pressure (continuous) and raised blood pressure/
hypertension (binary) were included. Exclusion criteria
were: (i) unavailability of results for the dominant model
(i.e. comparing CC individuals with T-allele carriers) or
sufficient data for its calculation; and (ii) articles not re-
porting original data.
The following characteristics of the included studies
were extracted:
i. first author’s name;
ii. year of publication;
iii. country and continent where the sample was taken;
iv. ancestry (European, African, Hispanic, Asian, Other
[e.g. admixed samples]);
v. sample size;
vi. prevalence of genetically defined LP;
vii. mean age;
viii. study design (unrelated individuals or family-based);
ix. ascertainment for a given phenotype [0¼ no; 1¼ yes
(e.g. controls and cases, respectively, in a case-control
study)];
x. cut-off used to determine overweight-obesity or
raised blood pressure/hypertension;
xi. covariates adjusted for in multivariable models. After
data extraction, the following variables were gener-
ated to indicate covariates adjusted for in individual
studies: sex (either sex-adjusted or sex-specific), age
(either age-adjusted or age-specific) and population
substructure (birthplace coordinates, region of resi-
dence, ethnic group, genetic admixture, etc).
xii. mean differences for continuous outcomes, and logistic
regression coefficients (and associated standard errors)
for binary outcomes (either directly from the publica-
tions or calculated based on data available) referring
to a comparison between CC individuals (reference)
and T-allele carriers (i.e. CT or TT individuals).
For some studies13,16,19,30,43–52 it was necessary to cal-
culate the standard error of the mean difference (SE). This
was performed as follows:
SE ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2CC=nCCþs2LP=nLP
q
;
where and si and ni are the standard deviation and sample
size, respectively, for non-LP (i¼CC) and LP (i¼LP)
individuals.
For some studies,16,19,30,47,50 it was necessary to com-
bine the data for CT and TT individuals to obtain mean
and standard deviations for T-carriers (or LP individuals).
The mean values were pooled as follows:
lLP ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðnCT  l2CTþnTT  l2TTÞ=ðnCTþnTTÞ
q
;
where lLP is the combined mean, and ni and li are the sam-
ple size and mean, respectively, for CT (i¼CT) and TT
(i¼TT) individuals.
Standard deviations were pooled as follows:
sLP ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½ðnCT  1Þs2CTþðnTT  1Þs2TT=ðnCTþnTTÞ
q
where sLP is the combined standard deviation, and ni and si
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are the sample size and standard deviation, respectively,
for CT (i¼CT) and TT (i¼TT) individuals.
When only the median and interquartile range were
available,30,49 the outcome was assumed to be approxi-
mately normally distributed, so the median was used as an
estimate of the mean. Assuming a normal distribution also
allows estimating the standard deviation, because the inter-
val from -0.674 toþ0.674 standard deviations would be
expected to contain 50% of the observations around the
mean. Therefore, the standard deviation was estimated by
dividing the interquartile range by 20.674. Given the
need to use the median as a proxy of the mean and that
skewness of BMI and systolic and diastolic blood pressures
were, respectively, 1.10, 0.61 and 0.55 (P< 0.001 in all
cases) in the 1982 Pelotas Birth Cohort, the resulting
standard deviation estimate was multiplied by 1.1 (i.e. a
10% increment) to avoid its underestimation due to
deviations from the normal distribution.
For binary outcomes, combining CT and TT into a
single group and/or estimating the necessary statistics was
performed when necessary,30,44,48,50,53 based on number
of individuals belonging to each outcome-LP status
combination, as presented in the publications.
For meta-analysis, pooled effect estimates were gener-
ated using random effects models. We opted to use random
effects only due to differences in characteristics of the
included studies (displayed in Supplementary Data File,
available as Supplementary data at IJE online) and to sub-
stantial between-study heterogeneity observed in three
studied outcomes. The following variables were explored
as heterogeneity sources in stratified analyses and random
effects meta-regression models: adjustment for at least sex,
age or population substructure, as well as adjustment for
each of these covariates individually. The following study
characteristics were also evaluated: sample size, mean age,
ancestry, continent and prevalence of LP. Publication bias
was evaluated through funnel plots and Egger’s regression.
Analyses of influence were performed as additional sensi-
tivity analyses by obtaining estimates excluding all studies,
one at a time.
Power calculations
Post hoc power calculations through simulations were per-
formed to evaluate our meta-analysis power to detect asso-
ciations of LP with systolic and diastolic blood pressure
assuming that they are entirely mediated by BMI.
Estimates were obtained from the aforementioned large
Danish study30—the largest study included in our meta-
analysis—and two Mendelian randomization studies.54,55
A detailed description of the simulations is provided in
Supplementary Methods (available as Supplementary data
at IJE online).
All analyses and simulations were performed using R
version 3.2.0 [http://www.r-project.org/].
Results
1982 Pelotas Birth Cohort
Supplementary Table 3 (available as Supplementary data
at IJE online) describes the studied individuals according
to sociodemographic, perinatal, lifestyle and biological
variables. Compared with non-drinkers, milk drinkers pre-
sented a higher proportion of males, maternal schooling,
family income at birth, birthweight, gestational age, pro-
portion of self-reported White skin colour, European gen-
omic ancestry, achieved schooling, household asset index,
height and yogurt and cottage cheese intake. Inverse asso-
ciations were observed for African and Native American
genomic ancestry, BMI and diastolic blood pressure.
A comparison of baseline characteristics of the whole
cohort and of the entire 2012–13 years-of-age follow-up
visit, with those included in the present study, is available
in Supplementary Table 4 (available as Supplementary
data at IJE online); 54% of the whole cohort and 77% of
the 2012–13 follow-up were included. Compared with the
whole cohort, studied individuals presented lower propor-
tions of males and of wealthier socioeconomic positions,
although there were no differences regarding birthweight.
Compared with the 2012–13 follow-up, studied subjects
presented higher prevalence of obesity (BMI 30 kg/m2).
In general, dairy consumption was positively associated
with socioeconomic status (Supplementary Table 5, avail-
able as Supplementary data at IJE online). The prevalence
of the lactase non-persistence genotype (CC) was higher
among self-reported Black (70.2%) compared with White
individuals (37.3%). Such differences did not remain after
controlling for genomic ancestry (Supplementary Table 6,
available as Supplementary data at IJE online). There was
no strong indication that the genotypic frequencies devi-
ated from Hardy-Weinberg Equilibrium when evaluating
all individuals [expected/observed frequencies: 43.1%/43.
7% (CC genotype), 45.1%/44.1% (CT genotype) and 11.
8/12.2% (TT genotype); P¼ 0.244] and stratifying by self-
reported skin colour (P 0.700). These results corroborate
the need to take ethnicity/ancestry into account in associ-
ations between rs4988235 and dairy consumption to min-
imize confounding due to population stratification.
Table 1 shows that milk intake was higher among T al-
lele-carriers, whose consumption was (in adjusted models)
42 (95% CI: 18; 67) ml/day higher than CC individuals.
The similarity of mean consumption values between CT
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and TT genotypes corroborates that the T-allele of the
rs4988235 SNP has a dominant effect on this outcome.
These associations differed between strata of European
genomic ancestry, with estimates of 73 (95%: 38; 108) and
12 (95% CI: -21; 46) in individuals with European genomic
ancestry85% and < 85%, respectively (interaction test
P-value ¼ 0.021). Reliable associations were not observed
for any other dairy product.
Milk intake was inversely associated with obesity and
blood pressure (Table 2). After controlling for sociodemo-
graphic variables (which did not substantially influence the
results), each increment of 1 dl/day was associated with
Table 1. Dairy intake in the 1982 Pelotas (Brazil) Birth Cohort according to rs4988235. Values are number of individuals (N),
means of daily intake (95% confidence intervals), R2-values, F-statistics (F) and P-values (P)
Dairy product Genetic model Unadjusted Adjusted for sex and genomic ancestry
All Europeana Otherb
(N¼2808) (N¼2806) (N¼1436) (N¼1370)
Milk (ml) Codominant Pinteraction¼0.063
P¼1.5104 P¼0.003 P¼2.6104 P¼0.740
C/C 0 (Ref.) 0 (Ref.) 0 (Ref.) 0 (Ref.)
C/T 50 (26; 75) 43 (18; 69) 75 (38; 113) 14 (21; 48)
T/T 49 (12; 86) 39 (0; 77) 67 (17; 116) 3 (64; 70)
Dominant Pinteraction¼0.021
R2¼0.63% R2¼0.42% R2¼1.14% R2¼0.04%
F¼17.71 F¼11.77 F¼16.46 F¼0.51
P¼2.7105 P¼0.001 P¼5.2105 P¼0.475
C/T or T/T 50 (27; 73) 42 (18; 67) 73 (38; 108) 12 (21; 46)
Yogurt (ml) Codominant Pinteraction¼0.644
P¼0.162 P¼0.193 P¼0.096 P¼0.868
C/C 0 (Ref.) 0 (Ref.) 0 (Ref.) 0 (Ref.)
C/T 13 (0; 25) 12 (1; 26) 19 (2; 36) 6 (15; 26)
T/T 5 (15; 24) 4 (16; 25) 7 (15; 30) 4 (36; 44)
Dominant Pinteraction¼0.454
R2¼0.11% R2¼0.09% R2¼0.25% R2¼0.02%
F¼3.00 F¼2.65 F¼3.62 F¼0.28
P¼0.083 P¼0.104 P¼0.057 P¼0.599
C/T or T/T 11 (1; 23) 11 (2; 23) 16 (0; 32) 5 (15; 25)
Cheese (g) Codominant Pinteraction¼0.658
P¼0.059 P¼0.035 P¼0.105 P¼0.223
C/C 0 (Ref.) 0 (Ref.) 0 (Ref.) 0 (Ref.)
C/T 0.6 (0.8; 2.0) 0.2 (1.2; 1.7) 0.7 (1.2; 2.6) 0.1 (2.2; 2.0)
T/T 1.9 (4.0; 0.2) 2.5 (4.7; 0.3) 1.9 (4.4; 0.6) 3.6 (7.7; 0.6)
Dominant Pinteraction¼0.578
R2¼0.00% R2¼0.01% R2¼0.00% R2¼0.02%
F¼0.02 F¼0.20 F¼0.00 F¼0.30
P¼0.902 P¼0.656 P¼0.988 P¼0.585
C/T or T/T 0.1 (1.2; 1.4) 0.3 (1.7; 1.1) 0.0 (1.8; 1.8) 0.6 (2.6; 1.5)
Cottage Codominant Pinteraction¼0.859
cheese (g) P¼0.971 P¼0.587 P¼0.689 P¼0.928
C/C 0 (Ref.) 0 (Ref.) 0 (Ref.) 0 (Ref.)
C/T 0.1 (0.5; 0.6) 0.2 (0.8; 0.3) 0.3 (1.2; 0.5) 0.1 (0.8; 0.6)
T/T 0.1 (0.7; 0.9) 0.4 (1.2; 0.5) 0.4 (1.6; 0.8) 0.2 (1.6; 1.1)
Dominant Pinteraction¼0.558
R2¼0.00% R2¼0.03% R2¼0.05% R2¼0.01%
F¼0.05 F¼0.96 F¼0.73 F¼0.12
P¼0.820 P¼0.326 P¼0.392 P¼0.727
C/T or T/T 0.1 (0.5; 0.6) 0.3 (0.8; 0.3) 0.4 (1.2; 0.5) 0.1 (0.8; 0.5)
aIndividuals with European genomic ancestry  85%.
bIndividuals with European genomic ancestry < 85%.
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0.26 (0.19; 0.33) kg/m2 lower BMI, 0.31 (95% CI: 0.16;
0.46) and 0.35 (95% CI: 0.23; 0.46) mmHg lower systolic
and diastolic blood pressure, respectively, as well as with
odds ratio of 0.93 (95% CI: 0.91; 0.96) and 0.93 (95% CI:
0.90; 0.96) for overweight-obesity and raised blood pres-
sure, respectively. There were no reliable associations sup-
porting effect modification by sex (P> 0.20 for all
outcomes) and European genomic ancestry (P¼ 0.12 for
all outcomes).
Supplementary Table 7 (available as Supplementary
data at IJE online) describes the association of genetically-
defined LP with potential confounders of the association of
milk intake with obesity and/or blood pressure. In un-
adjusted analyses, LP individuals had 0.4 (95% CI: 0.1; 0.
7) more complete years of education than non-LP individ-
uals, as well as household asset index higher in 0.1 (95%
CI: 0.1; 0.2) standard deviation. However, after control-
ling for genomic ancestry, the respective coefficients were -
0.1 (95% CI: -0.5; 0.2) and 0.0 (95% CI: 0.1; 0.1). The
odds of LP among current smokers was 1.4 (95% CI: 1.1;
1.6) times higher in never smokers in adjusted models.
There was no strong indication that any of the reported as-
sociations differ according to milk intake status, except for
alcohol intake: compared with non-LP, LP status was asso-
ciated with 2.9 (95% CI: 5.5; 0.3) g/day less alcohol intake
among non-milk drinkers, and 0.5 (0.7; 1.6) g/day more
among milk drinkers.
There were no strong associations of genetically defined
LP with obesity or blood pressure (Table 3), although there
was some indication for BMI. In unadjusted models, BMI
was 0.27 (95% CI: 0.15; 0.69) kg/m2 higher in LP indi-
viduals. Adjusting for genomic ancestry increased the mag-
nitude of the estimate to 0.44 (95% CI: 0.00; 0.88). These
results were directionally consistent with the point odds
ratio estimate for overweight-obesity [1.09 (95% CI: 0.93;
1.28)]. Moreover, point estimates of both outcomes were
directionally consistent comparing unadjusted and ad-
justed models, as well as strata of European genomic an-
cestry and of milk intake status (Supplementary Table 8,
available as Supplementary data at IJE online). For sys-
tolic, diastolic and raised blood pressure, point estimates
were inconsistent comparing unadjusted with adjusted
models, but all unadjusted 95% CIs included the respective
adjusted point estimate and vice versa. Moreover, point es-
timates for systolic blood pressure and raised blood pres-
sure were directionally inconsistent between strata of
European genomic ancestry, with some indication of inter-
action (although 95% CIs were wide) for raised blood
pressure: odds ratio of 1.20 (95% CI: 0.93; 1.55) and 0.87
(95% CI: 0.67; 1.13) in individuals with European
genomic ancestry  85% and < 85%, respectively.
Systematic review and meta-analysis
After duplicate removal, 452 records were screened based
on their titles and abstracts, which yielded 30 records
(shown in Sheet 1 of Supplementary Data File, available as
Supplementary data at IJE online). After accessing the full
texts, 16 records were included.13,19,30,36,37,45–53 One add-
itional record16 was identified in the reference lists of the
included records, totalling 17 records (Supplementary
Figure 2, available as Supplementary data at IJE online).
Study-level characteristics and results are displayed in
Sheets 2–6 of Supplementary Data File.
Table 4 displays meta-analysis results (Supplementary
Figures 3–8 present forest and funnel plots for all out-
comes). BMI was 0.17 (95% CI: 0.07; 0.27) kg/m2 higher
in LP individuals, and the pooled odds ratio for over-
weight-obesity was 1.09 (95% CI: 1.02; 1.17). Results for
diastolic blood pressure were also suggestive of a positive
association with LP, with a mean difference coefficient of
Table 2. Association of milk intake (in decilitres per day) with
studied outcomes in the 1982 Pelotas (Brazil) Birth Cohort.
Values are number of individuals (N), linear regression coeffi-
cients (b) or odds ratio (OR), 95% confidence intervals (95%
CI) and P-values (P)
Outcome Unadjusted Adjusteda
BMI (kg/m2)
N 2761 2595
P 1.51013 3.21013
b (95% CI) 0.25 (0.32; 0.18) 0.26 (0.33; 0.19)
Overweight-obesityb
N 2761 2595
P 1.8107 7.2108
OR (95% CI) 0.94 (0.91; 0.96) 0.93 (0.91; 0.96)
Systolic BP (mmHg)
N 2806 2638
P 0.001 3.7105
b (95% CI) 0.27 (0.44; 0.11) 0.31 (0.46; 0.16)
Diastolic BP (mmHg)
N 2806 2638
P 2.0108 2.9109
b (95% CI) 0.32 (0.43; 0.21) 0.35 (0.46; 0.23)
Raised BPc
N 2806 2638
P 2.9104 1.9105
OR (95% CI) 0.95 (0.92; 0.98) 0.93 (0.90; 0.96)
aAdjusted for sex, maternal schooling at birth (0–4, 5-8, 9–11 or  12 com-
plete years), family income at birth ( 1, 1.1–3, 3.1–6, 6.1–10 or > 10 min-
imum wages), African and Native American genomic ancestry (continuous, as
% values), household asset index at 30–31 years of age in quintiles and
achieved schooling at 30–31 years of age (0-4, 5–8, 9–11 or  12 complete
years).
bBMI  25 kg/m2.
cSystolic BP  130 mmHg or diastolic BP  85 mmHg.
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Table 3. Association of genetically defined LP (reference group: non-LP individuals) with studied outcomes in the 1982 Pelotas
(Brazil) Birth Cohort. Values are number of individuals (N), linear regression coefficients (b) or odds ratio (OR), 95% confidence
intervals (95% CI) and P-values (P)
Outcome Unadjusted Adjusted for sex and genomic ancestry
All Europeana Otherb
BMI (kg/m2) Pinteraction¼0.467
N 2782 2780 1427 1353
P 0.207 0.052 0.384 0.074
b (95% CI) 0.27 (0.15; 0.69) 0.44 (0.00; 0.88) 0.26 (0.33; 0.86) 0.60 (0.06; 1.25)
Overweight-obesityc Pinteraction¼0.612
N 2782 2780 1427 1353
P 0.565 0.294 0.799 0.259
OR (95% CI) 1.05 (0.90; 1.22) 1.09 (0.93; 1.28) 1.03 (0.82; 1.29) 1.14 (0.91; 1.43)
Systolic BP (mmHg) Pinteraction¼0.520
N 2840 2838 1453 1385
P 0.503 0.362 0.963 0.258
b (95% CI) 0.35 (1.38; 0.67) 0.43 (0.50; 1.37) 0.03 (1.30; 1.24) 0.79 (0.58; 2.16)
Diastolic BP (mmHg) Pinteraction¼0.665
N 2840 2838 1453 1385
P 0.773 0.467 0.957 0.390
b (95% CI) 0.10 (0.80; 0.60) 0.27 (0.45; 0.99) 0.03 (0.97; 1.02) 0.46 (0.59; 1.50)
Raised BPd Pinteraction¼0.044
N 2840 2838 1453 1385
P 0.496 0.684 0.172 0.304
OR (95% CI) 0.94 (0.80; 1.11) 1.04 (0.87; 1.25) 1.20 (0.93; 1.55) 0.87 (0.67; 1.13)
aIndividuals with European genomic ancestry < 85%.
bIndividuals with European genomic ancestry < 85%.
cBMI  25 kg/m2.
dSystolic BP 130 mmHg or diastolic BP 85 mmHg.
Table 4. Random effects meta-analytical linear regression coefficient (b) or odds ratio (OR) estimates of BMI, overweight-obes-
ity, systolic, diastolic and raised blood pressure, according to genetically defined LP (reference group: non-LP individuals)
Outcome BMI (kg/m2)a Overweight-obesityb Systolic BP (mmHg)a Diastolic BP(mmHg)a Raised BPb
Number of
Estimates 14 5 7 7 4
Individuals 142864 102640 112440 112442 101507
Heterogeneity
I2 (%) 83.6 8.0 55.2 0.0 52.1
s2 0.035 0.001 0.445 0.0 0.016
P-value 1.110-21 0.365 0.022 0.748 0.079
Meta-analysis
b or OR (95% CI) 0.17 (0.07; 0.27) 1.09 (1.02; 1.17) 0.04 (0.73; 0.64) 0.02 (0.00; 0.04) 0.98 (0.84; 1.16)
P-value 0.001 0.015 0.902 0.098 0.846
Egger’s regression
Bias (95% CI)c 1.11 (0.22; 2.44) 0.83 (0.80; 2.47) 0.16 (1.50; 1.18) 0.25 (0.44; 0.94) 0.37 (3.75; 3.01)
P-value 0.097 0.230 0.786 0.415 0.750
aLinear regression coefficients (b) were reported for these outcomes.
bOdds ratio (OR) were reported for these outcomes.
cCorresponds to Egger’s regression intercept, which was performed using either b or log(OR) estimates.
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0.02 (95% CI: 0.00; 0.04) mmHg comparing LP with non-
LP individuals, although the confidence intervals poorly
included 0. However, this was inconsistent with the pooled
point odds ratio estimate for raised blood pressure (0.98)
and the pooled point mean difference for systolic blood
pressure (0.04 mmHg), with both confidence intervals
largely including 1 and 0, respectively.
In influence analysis, estimates for BMI ranged from
0.08 to 0.20 and none of the 95% confidence intervals
included zero. Regarding overweight-obesity, the odds
ratio estimates ranged from 0.07 to 1.15 and only in one
case the 95% confidence intervals included 1; in this situ-
ation, the estimate was 1.10 (95% CI: 1.00; 1.20).
Although forest plots and the I2 statistic suggested
considerable heterogeneity for BMI and systolic and
raised blood pressure, the number of estimates only
allowed exploring potential heterogeneity sources for
BMI. Excluding a single small outlying study (which re-
ported a mean BMI difference of 5.3 kg/m2 in a sample
size of 64 individuals) reduced the I2 statistic to 30.2%
and yielded an estimate of 0.08 (95% CI: 0.04; 0.12).
Such exclusion also reduced Egger’s regression intercept
from 1.11 (95% CI: -0.22; 2.44)—which was suggestive
of publication bias, although confidence intervals were
wide—to 0.41 (95% CI: -0.27; 1.09).
Meta-analytical estimates for BMI within subgroups of
study characteristics are shown in Table 5. Regarding het-
erogeneity, the most important characteristics were ances-
try and LP prevalence, which explained about 25% and
40%, respectively, of the heterogeneity in the estimates.
When comparing unadjusted with adjusted estimates, the
pooled effect estimates were considerably larger in
unadjusted studies regardless of the covariate. After
excluding the aforementioned outlying study, adjusting for
Table 5. Random effects meta-analysis and meta-regression results for the mean difference (b) in BMI comparing LP with non-
LP (reference group) individuals, stratifying according to study characteristics
Characteristic Number of Meta-analysis Meta-regression
Estimates Individuals b (95% CI) P-value Adjusted-R2 P-value
Sample size
64-529 10 3518 0.50 (0.75; 1.76) 0.431 3.81 0.300
580–2104 9 11788 0.13 (0.02; 0.28) 0.081
2126–97811 9 127558 0.08 (0.05; 0.11) 7.110-7
Age
9–13 3 1470 0.14 (0.29; 0.56) 0.529 0.00 0.970
26–55 16 28611 0.24 (0.08; 0.40) 0.004
56–69 9 112783 0.10 (0.03; 0.18) 0.006
Ancestry
European 25 141153 0.08 (0.04; 0.12) 3.710-4 24.62 0.010
Other 3 1711 1.92 (1.02; 4.86) 0.201
Continent
European 23 139392 0.08 (0.03; 0.12) 4.810-4 14.68 0.058
Other 5 3472 1.12 (0.61; 2.86) 0.204
LP prevalence
50% 2 1417 2.94 (1.67; 7.55) 0.212 39.63 0.001
51–80% 11 11180 0.23 (0.01; 0.45) 0.038
 80% 15 130267 0.06 (0.03; 0.10) 1.210-4
Adjustment
Any covariate
No 13 107239 0.65 (0.16; 1.14) 0.009 5.02 0.090
Yes 15 35625 0.06 (0.02; 0.09) 0.001
Sex
No 15 111530 0.50 (0.22; 0.77) 4.310-4 0.00 0.206
Yes 13 31334 0.05 (0.01; 0.09) 0.010
Age
No 17 110640 0.48 (0.15; 0.80) 0.004 0.00 0.217
Yes 11 32224 0.06 (0.02; 0.10) 0.002
Population substructure
No 19 118203 0.38 (0.17; 0.58) 4.310-4 0.00 0.284
Yes 9 24661 0.04 (0.00; 0.08) 0.066
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any covariate and adjusting for population substructure
were the factors that explained most of the heterogeneity
(about 65% and 60%, respectively). However, all pooled
unadjusted estimates were larger than the corresponding
adjusted estimates, regardless of the covariate (Table 6).
Power analysis
Supplementary Tables 9 and 10 (available as Supplementary
data at IJE online) display the expected results of the LP-
blood pressure associations assuming that they are entirely
mediated by BMI. Even in a sample size of 300 000 individ-
uals, statistical power was low, ranging from 5% to 49%
for systolic and 5% to 40% for diastolic blood pressure, de-
pending on LP prevalence and strength of LP-BMI associ-
ations. In this sample size, the point effect estimates ranged
from 0.016 to 0.192 and 0.007 to 0.088 mmHg,
respectively, comparing LP to non-LP (reference group)
individuals.
Discussion
In this study, the LP SNP rs4988235 was associated with
daily milk consumption in a population-based sample in
South Brazil. In conventional observational analysis, there
was an inverse association of milk intake with obesity and
blood pressure. However, Mendelian randomization ana-
lyses based on genetically defined LP did not confirm these
associations. Moreover, LP was positively associated with
BMI and overweight-obesity in our meta-analysis.
The aforementioned meta-analysis36 had already de-
tected that LP individuals have higher BMI compared with
non-LP subjects. Our systematic literature review identi-
fied several additional reports of the LP-BMI association
Table 6. Random effects meta-analysis and meta-regression results for the mean difference (b) in BMI comparing LP with non-
LP (reference group) individuals, stratifying according to study characteristics, excluding an outlying study
Characteristic Number of Meta-analysis Meta-regression
Estimates Individuals b (95% CI) P-value Adjusted-R2 P-value
Sample size
64–529 9 3454 0.06 (0.31; 0.43) 0.754 0.00 0.876
580–2104 9 11788 0.13 (0.02; 0.28) 0.081
2126-97811 9 127558 0.08 (0.05; 0.11) 7.110-7
Age
9–13 3 1470 0.14 (0.29; 0.56) 0.529 0.00 0.739
26–55 15 28547 0.06 (0.00; 0.13) 0.038
56–69 9 112783 0.10 (0.03; 0.18) 0.006
Ancestry
European 25 141153 0.08 (0.04; 0.12) 3.710-4 0.00 0.481
Other 2 1647 0.26 (0.41; 0.93) 0.446
Continent
European 23 139392 0.08 (0.03; 0.12) 4.810-4 0.00 0.581
Other 4 3408 0.18 (0.20; 0.56) 0.345
LP prevalence
50% 1 1353 0.60 (0.06; 1.25) 0.074 16.63 0.129
51–80% 11 11180 0.23 (0.01; 0.45) 0.038
 80% 15 130267 0.06 (0.03; 0.10) 1.210-4
Adjustment
Any covariate
No 12 107175 0.25 (0.11; 0.40) 0.001 64.98 0.011
Yes 15 35625 0.06 (0.02; 0.09) 0.001
Sex
No 14 111466 0.16 (0.07; 0.26) 0.001 27.90 0.061
Yes 13 31334 0.05 (0.01; 0.09) 0.010
Age
No 16 110576 0.19 (0.05; 0.32) 0.006 15.87 0.104
Yes 11 32224 0.06 (0.02; 0.10) 0.002
Population substructure
No 18 118139 0.14 (0.08; 0.21) 2.110-5 59.78 0.017
Yes 9 24661 0.04 (0.00; 0.08) 0.067
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published after this study, as well as earlier reports, thus
allowing expansion of this study. Moreover, a recent study
on 97 811 Danish individuals failed to detect strong associ-
ations of LP with BMI and overweight-obesity.30 Our find-
ings confirmed the previously reported positive association
of LP with BMI, which was corroborated by an association
with overweight-obesity in the same direction. Although
the sample size of the Danish study represented 64% and
95% of the pooled sample sizes for BMI and overweight-
obesity (respectively), its actual weight in the meta-analysis
is lower due to the very low prevalence of lactase non-
persistence in this study. Moreover, influence analysis did
not indicate that any single study was substantially influ-
encing the pooled estimates and, in the subgroup analyses
performed for BMI, all pooled point estimates were direc-
tionally consistent. In additional analyses performed using
fixed effects, the pooled estimates for BMI and overweight
obesity were 0.08 (95% CI: 0.05; 0.11) and 1.09 (1.02;
1.17), respectively, corroborating the findings obtained
with random effects. These findings suggest a positive
causal effect of milk intake on BMI and overweight-
obesity, suggesting that the negative associations observed
in conventional observational analysis were due to residual
confounding or other limitations of observational studies.
A recent large study in the Danish population
(n¼ 98 529) failed to detect an association of LP with
blood pressure and hypertension.37 These conclusions
were not substantially influenced by adding the reports
identified in our systematic literature review and the results
for the 1982 Pelotas Birth Cohort. Based on our power cal-
culations, sample sizes larger than 300 000 individuals
would be required for properly-powered evaluations of the
LP-blood pressure association under the assumption that
BMI entirely mediates these associations. Although this
suggests that our meta-analysis could be underpowered, it
also suggests that even moderate blood pressure-lowering
effects of milk could overcome any hypertensive effects
due to its positive association with BMI and be detectable
in our meta-analysis. Although 95% confidence intervals
for diastolic and raised blood pressure were wide (due to
heterogeneity between estimates), the point estimates were
small and inconsistent when comparing systolic and raised
blood pressure with diastolic blood pressure. Moreover, all
these estimates were based on data for more than 100 000
individuals, and about half of them suggested a negative
association whereas the remaining suggested a positive as-
sociation. Therefore, although our findings are not entirely
conclusive regarding whether or not milk intake is causally
associated with blood pressure due to potential power
issues, they are not supportive of a strong negative effect.
A negative association between milk intake and hyper-
tension has been consistently reported in observational
studies, as shown in two meta-analyses of cohort studies:
one included five studies, with approximately 45 000 indi-
viduals and 15 000 cases of raised blood pressure;23 and
the other (which observed a dose-response effect) included
nine studies, with approximately 57 000 individuals and
15 500 hypertension cases.24 Two meta-analyses (includ-
ing 12 and 14 studies, with 623 and 1306 individuals, re-
spectively25,26) of RCTs suggested that the milk-derived
tripeptides isoleucine-proline-proline and valine-proline-
proline have blood pressure-lowering effects. Moreover,
pooled estimates from 14 trials involving a total of 702 in-
dividuals indicated that probiotic fermented milk has ef-
fects on blood pressure in the same direction56 when
compared with placebo.
In spite of the aforementioned studies, the strength of
the evidence supporting a beneficial effect of milk intake
on blood pressure is considered moderate.57 Findings from
RCTs of specific milk compounds (e.g. tripeptides) may
not be directly transposable into a feasible public health
intervention such as stimulating milk consumption, for sev-
eral reasons. For example, intake of milk of higher fat con-
tent may predominate over lower fat milk in a given
population, therefore contributing to greater fat intake.
Moreover, RCTs assessing dietary habits are often limited
to short time periods and to specific nutritional compounds
that can be delivered via capsules or alternatives that allow
double blinding. In contrast, Mendelian randomization
(depending on the genetic variant used as proxy) allows
the study of lifelong effects of a given dietary item as a
whole on the outcome: in the case of rs4988235, it is
known that lactase levels decrease markedly after weaning
in CC individuals.1 Furthermore, this design reveals the ef-
fects of the exposure to be targeted by public health inter-
ventions in real populations, rather than specific
compounds in selected sub-populations who are willing to
participate in a RCT.
One of the main potential limitations of our study
(which is inherent in the Mendelian randomization design)
is the assumption of no effects of the genetic variant on the
outcome other than through the exposure of interest (i.e.
no horizontal pleiotropy). In this regard, we used a genetic
variant with strong functional evidence supporting that its
phenotypic implications are mediated by milk consump-
tion due to LP status. We tested the association of
rs4988235 with intake of different dairy products and
observed reliable associations only with milk. Moreover, a
recent study on almost 100 000 Danish individuals failed
to detect associations with intake of fruit, vegetables, fish,
fast food and soda drinks after correcting for multiple test-
ing.37 These results suggest that the effect of this SNP on
milk consumption is disentangled from other dietary hab-
its. This is an important consideration, given that milk
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intake is often part of wider dietary patterns,58–60 which
can distort observational associations. In our study, reli-
able associations were also not detected with sociodemo-
graphic, perinatal, lifestyle or biological measures, except
for smoking status. This latter association was not detected
in one of the aforementioned large Danish studies,37 rais-
ing the possibility that the finding in our study was due to
multiple testing.
For some exposures such as alcohol intake, it is possible
to perform Mendelian randomization stratifying by never
vs ever experimenters to gain insights into potential hori-
zontal pleiotropic effects. This is based on the notion that
the effect of genetic variants would be on continuation/
addition rather than initiation, so one would expect to see
associations only among ever experimenters unless the gen-
etic instruments are associated with the outcome through
pathways not mediated by alcohol intake.61 In the 1982
Pelotas Birth cohort, stratifying by milk intake yielded
larger effect magnitudes among non-milk drinkers (al-
though all interaction test P-values were > 0.20). Although
this is in accordance with rs4988235 having pleiotropic ef-
fects, it is important to note that it was not possible to
stratify in never vs ever milk drinkers since this informa-
tion was not available and, even if it were, the prevalence
of never milk drinkers after weaning would most likely be
very low. We stratified based on current milk intake status,
so it is possible that some individuals stopped drinking
milk due to LP-associated symptoms. By conditioning on a
potential mediator, we might not only bias downwards the
effect estimates associated with LP status, but also intro-
duce collider bias.62 Indeed, such adjustment may have cre-
ated a statistical association between LP and alcohol
intake among non-milk drinkers, although there was no
strong statistical evidence supporting different associations
with LP between milk intake strata for the remaining cova-
riates. Moreover, the aforementioned Danish studies did
not detect reliable LP-milk intake interactions regarding
overweight-obesity30 or blood pressure. However, such
interactions were detected regarding sex (likely explained
by collider bias since milk intake is associated with sex
and, conceptually, neither genetically defined LP nor milk
intake can influence sex determination) and other
covariates.37
Another potential source of confounding in Mendelian
randomization studies is population substructure, which
was reported to interfere with associations of rs4988235
with height in European American populations63 and with
several outcomes in Britain.19 In the 1982 Pelotas Birth
Cohort, such confounding could be expected to be even
more pronounced due to multi-ethnicity and ethnic-related
socioeconomic inequities that exist in this population.64
To control for this effect, we explored genome-wide
genotyping data to calculate genomic ancestry to be used
as covariates. This adjustment eliminated the strong statis-
tical association between genetically defined LP and socio-
economic variables observed in unadjusted analyses, which
would be expected to occur due to population stratifica-
tion. Regarding the meta-analysis, adjusting for population
substructure accounted for 60% of the heterogeneity of
LP-BMI estimates after excluding a single outlying study
(but not when this study–which fulfilled pre-defined inclu-
sion criteria–was included), with adjusted estimates being
lower than unadjusted ones. However, the LP-BMI associ-
ation in the 1982 Pelotas Birth Cohort was strengthened,
rather than weakened, once population stratification was
adjusted for. Moreover, most of the studies were per-
formed in ethnically homogeneous populations, and the es-
timates adjusted for other covariates (i.e. sex and age) were
similarly larger than their unadjusted counterparts. This
suggests that the difference in the magnitudes of estimates
adjusted and unadjusted for population stratification
might be related to contextual factors (e.g. characteristics
of studies that performed multivariable analyses) rather
than residual confounding in unadjusted estimates.
It has been suggested that cultural factors associated
with acceptance and generality of milk intake influence the
association between the latter and genetically defined
LP.19,20 Bergholdt and colleagues,37 based on data from
six European countries, observed that in general the differ-
ence in milk intake comparing LP vs non-LP individuals
was larger in countries with higher mean levels of milk in-
take. This is a potential explanation for the stronger associ-
ation between LP and milk intake in individuals with at
least 85% of European genomic ancestry compared with
others in the 1982 Pelotas Birth Cohort, because the latter
are, on average, poorer, and socioeconomic position was
positively associated with dairy intake in this study.
Although this complicates interpreting our meta-analytical
findings in units of milk intake, this provides an opportun-
ity to explore potential horizontal pleiotropic effects of the
rs4988235 variant. This is because the association of LP
with health outcomes–comparing populations where the
LP-milk intake association is stronger with populations
where this association is weaker–would be expected (in
case of no horizontal pleiotropy) to be either stronger in
the first (if milk intake has causal effects on the studied
outcome) or similar and weak in both (in the case of no
causal effects). It was not possible to perform such analysis
in the present study due to unavailability of the LP-milk in-
take association in some studies, as well as to heterogeneity
in milk intake measurement.
Another potential limitation is the use of a single genetic
predictor of LP instead of including other variants at the
MCM6 region. This is of special importance given that
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26 haplotypes were derived from 10 LP-related SNPs in
Southern (European ancestry: n¼321; African ancestry:
n¼ 182), North Eastern (n¼ 262) and Northern (n¼ 200)
Brazilian individuals,10 corroborating the notion that gen-
etic variants other than rs4988235 should be considered
when studying genetically defined LP in non-European
populations.65 However, the most polymorphic variants
(rs4988235 and rs182549) were in high linkage disequilib-
rium–similarly to the present study (data not shown).
Moreover, only nine individuals were heterozygous for the
remaining variants (rs4988234, rs145946881, rs4988233
and -13779 G>C–not included in dbSNP) in the MCM6
region. Northern individuals presented the highest variabil-
ity, whereas Southern individuals (the most similar to the
1982 Pelotas Birth Cohort) presented one case of heterozy-
gozity for each of the rs145946881 and -13779 G>C vari-
ants. Importantly, in vitro effects on gene expression are
available for the former only.66 Therefore, although geno-
typing variants other than rs4988235 may be important
for diagnostic purposes, it is unlikely to have substantial
impacts on epidemiological investigations, especially in
samples of high European ancestry (such as in South
Brazil67) and when estimating the prevalence of LP is not
the primary goal. Although data for non-Europeans were
included in the meta-analysis, most of the estimates were
generated in individuals of European ancestry. Moreover,
it was necessary to focus on a single (rather than several)
genetic variant to improve between-study comparability,
given the unavailability of LP-milk intake associations in
comparable milk intake scales (e.g. mean difference in ml/
day comparing LP and non-LP individuals) across studies
(as mentioned above).
Considering that obesity and elevated blood pressure
are important risk factors for cardiovascular diseases,
identifying their determinants is critical for efficient pub-
lic health interventions aimed at reducing the burden of
disease at the population level. In our study, analyses
based on genetically defined LP suggested that simply
increasing milk intake in the target population would
likely increase its BMI and prevalence of overweight-
obesity and, at best, not influence blood pressure. Our
findings are in accordance with the notion that the results
from RCTs evaluating pressure-lowering effects of milk
compounds do not imply that simply increasing milk in-
take in the general population would promote the ex-
pected health benefits.
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